-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LP-184 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LP-184 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LP-184 in Solid Tumor Drug Details: LP-184 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LP-184 in Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LP-184 in Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LP-184 in Lung Cancer Drug Details: LP-184 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LP-184 in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LP-184 in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LP-184 in Ovarian Cancer Drug Details: LP-184 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LP-184 in Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LP-184 in Prostate Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LP-184 in Prostate Cancer Drug Details: LP-184 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LP-184 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LP-184 in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LP-184 in Colorectal Cancer Drug Details: LP-184 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LP-184 in Liver Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LP-184 in Liver Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LP-184 in Liver Cancer Drug Details: LP-184 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LP-184 in Bladder Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LP-184 in Bladder Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LP-184 in Bladder Cancer Drug Details: LP-184 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LP-184 in Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LP-184 in Glioblastoma Multiforme (GBM) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LP-184 in Glioblastoma Multiforme (GBM) Drug Details: LP-184 is under...
-
Product Insights
NewWilms’ Tumor (Nephroblastoma) – Drugs In Development, 2024
Empower your strategies with our Wilms' Tumor (Nephroblastoma) – Drugs In Development, 2024 report and make more profitable business decisions. Wilms' Tumor also known as Nephroblastoma is a type of cancer in one kidney commonly seen in children and is the most common cancer in children around 3-5 years of age and rarely observed in adults. Although the exact cause is idiopathic genetic alterations in WT1, CTNNB1, and WTX, TP53 and MYNC are believed to cause this. Tumor originates from the...
-
Product Insights
NewRhabdomyosarcoma – Drugs In Development, 2024
Empower your strategies with our Rhabdomyosarcoma – Drugs In Development, 2024 report and make more profitable business decisions. Rhabdomyosarcoma (RMS) is a malignant tumor of connective tissue in which abnormal cells are thought to arise from primitive muscle cells. Symptoms include pain, fever, purplish discoloration of the eye, hearing loss, headaches, bulging of the eye, or a droopy eyelid and tingling or weakness. Predisposing factors include age, inherited conditions (neurofibromatosis type 1, Costello syndrome) and family history. Treatment includes surgery, chemotherapy,...